There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

Earlier in October, Pfizer Inc (NYSE: PFE ... budget by $1.1 billion over the next three years while it aims to get FDA ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.

On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for ...

Here's what they found. Pfizer-BioNTech: The Pfizer-BioNTech vaccine was the first COVID vaccine to receive FDA Emergency Use Authorization from the Food and Drug Administration back in December 2020.

Pfizer (PFE, Financials) announced plans to invest $1 billion in China over the next five years to enhance research and ...

The shift to a clear recommendation for vaccination goes beyond the prior guidance "just to encourage adults to talk to their ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer ...

Abrysvo is the first vaccine for the respiratory syncytial virus that is indicated for adults younger than 50, the drugmaker ...